Ksilink and Anagenesis Biotechnologies

Posted by | No Tags | news | Comments Off on Ksilink and Anagenesis Biotechnologies

logo_anagenesis

 

On February 2nd 2016, Ksilink and Anagenesis Biotechnologies announce a collaborative research agreement to apply stem-cell derived disease models of Duchenne Muscular Dystrophy to small molecule therapies discovery and development.

 

Download the press release in English here.

 

Download the press release in French here.


No Comments

Comments are closed.